Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-27 @ 9:45 AM
Study NCT ID:
NCT06336434
Status:
WITHDRAWN
Last Update Posted:
2025-07-31
First Post:
2024-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-21
First Submit QC Date:
None
Study First Post Date:
2024-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-28
Last Update Post Date:
2025-07-31
Last Update Post Date Type:
ACTUAL